1.
Ther Adv Infect Dis
; 7: 2049936120952605, 2020.
Artículo
en Inglés
| MEDLINE
| ID: mdl-32922782
RESUMEN
High-dose tigecycline therapy is gaining wide acceptance in treating infections caused by multidrug-resistant bacteria. There are no reports of cutaneous hyperpigmentation with the use of high-dose tigecycline. Here we report a case of a woman who developed reversible cutaneous hyperpigmentation within 48 h of receiving high-dose tigecycline.